Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:01 am Purchase |
2023-12-31 | 13G | Semtech Corporation SMTC |
Point72 Asset Management, L.P. | 1,684,160 2.600% |
1,684,160 (New Position) |
Filing History |
| 2024-02-14 07:01 am Sale |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management, L.P. | 2,834,499 3.300% |
-685,903 (-19.48%) |
Filing History |
| 2024-02-14 07:00 am Sale |
2023-12-31 | 13G | Biohaven Ltd. BHVN |
Point72 Asset Management, L.P. | 2,552,822 3.200% |
-1,508,521 (-37.14%) |
Filing History |
| 2024-02-14 06:45 am Sale |
2023-12-31 | 13G | Bionomics Limited BNOX |
Point72 Asset Management, L.P. | 4,965,000 4.000% |
-4,959,390 (-49.97%) |
Filing History |
| 2024-02-14 06:45 am Sale |
2023-12-31 | 13G | Rapid7, Inc. RPD |
Point72 Asset Management, L.P. | 1,877,611 3.100% |
-1,214,659 (-39.28%) |
Filing History |
| 2024-02-14 06:30 am Sale |
2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management, L.P. | 3,997,545 4.500% |
-87,999 (-2.15%) |
Filing History |
| 2024-02-14 06:30 am Sale |
2023-12-31 | 13G | Chewy, Inc. CHWY |
Point72 Asset Management, L.P. | 1,591,442 1.300% |
-5,114,441 (-76.27%) |
Filing History |
| 2024-02-14 06:29 am Sale |
2023-12-31 | 13G | Inari Medical, Inc. NARI |
Point72 Asset Management, L.P. | 1,175,150 2.000% |
-1,620,202 (-57.96%) |
Filing History |
| 2024-02-14 06:17 am Sale |
2023-12-31 | 13G | Pulmonx Corporation LUNG |
Point72 Asset Management, L.P. | 1,546,089 4.000% |
-425,721 (-21.59%) |
Filing History |
| 2024-02-14 06:16 am Sale |
2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Point72 Asset Management, L.P. | 468,821 0.200% |
-7,646,069 (-94.22%) |
Filing History |
| 2024-02-14 06:15 am Sale |
2023-12-31 | 13G | Fastly, Inc. FSLY |
Point72 Asset Management, L.P. | 68,184 0.100% |
-6,141,507 (-98.90%) |
Filing History |
| 2024-02-14 06:11 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 209,971 0.200% |
-4,323,785 (-95.37%) |
Filing History |
| 2024-02-14 06:03 am Sale |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Point72 Asset Management, L.P. | 825,000 3.800% |
-425,000 (-34.00%) |
Filing History |
| 2024-02-14 06:01 am Sale |
2023-12-31 | 13G | CUTERA INC CUTRQ |
Point72 Asset Management, L.P. | 214,800 1.100% |
-929,607 (-81.23%) |
Filing History |
| 2024-02-12 4:24 pm Purchase |
2024-02-02 | 13G | Annexon, Inc. ANNX |
Point72 Asset Management, L.P. | 4,868,603 6.200% |
4,868,603 (New Position) |
Filing History |
| 2024-02-09 4:08 pm Purchase |
2024-02-06 | 13G | Vaccinex, Inc. VCNX |
Point72 Asset Management, L.P. | 413,818 9.900% |
413,818 (New Position) |
Filing History |
| 2024-02-08 4:53 pm Purchase |
2024-02-07 | 13G | JOYY Inc. JOYY |
Point72 Asset Management, L.P. | 45,329,900 5.100% |
45,329,900 (New Position) |
Filing History |
| 2024-02-07 4:25 pm Purchase |
2024-02-06 | 13G | Alto Neuroscience, Inc. ANRO |
Point72 Asset Management, L.P. | 1,692,778 6.300% |
1,692,778 (New Position) |
Filing History |
| 2024-02-05 4:34 pm Purchase |
2024-02-02 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management, L.P. | 1,612,639 5.300% |
1,612,639 (New Position) |
Filing History |
| 2024-01-31 4:55 pm Purchase |
2024-01-30 | 13G | Iterum Therapeutics plc ITRM |
Point72 Asset Management, L.P. | 850,001 6.300% |
850,001 (New Position) |
Filing History |